Buspirone: anxiolytic? (Record no. 2874341)

MARC details
000 -LEADER
fixed length control field 01380 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250512023015.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 198603s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0278-5846
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/0278-5846(85)90032-6
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Pecknold, J C
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19860318
245 00 - TITLE STATEMENT
Title Buspirone: anxiolytic?
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Progress in neuro-psychopharmacology & biological psychiatry
Date of publication, distribution, etc. 1985
300 ## - PHYSICAL DESCRIPTION
Extent 639-42 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-Anxiety Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anxiety
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Buspirone
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diazepam
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Psychiatric Status Rating Scales
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sex Factors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Familamiri, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chang, H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wilson, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Alarcia, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name McClure, D J
773 0# - HOST ITEM ENTRY
Title Progress in neuro-psychopharmacology & biological psychiatry
Related parts vol. 9
-- no. 5-6
-- p. 639-42
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/0278-5846(85)90032-6">https://doi.org/10.1016/0278-5846(85)90032-6</a>
Public note Available from publisher's website

No items available.